Expansion of hematopoietic stem/progenitor cells

被引:23
作者
Hai-Jiang, Wu [1 ]
Xin-Na, Deng [2 ]
Hui-Jun, Duan [1 ]
机构
[1] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Dept Oncol, Affiliated Hosp 4, Shijiazhuang, Peoples R China
关键词
D O I
10.1002/ajh.21262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematopoietic stem/progenitor cells (HSPCs) transplantation is hampered by the low number of stem cells per sample. To tackle this obstacle, several protocols for expansion of HSPCs in vitro are currently in development, such as the use of cytokine cocktails, coculture with mesenchymal stem cells as feeder cells, and cell culture in bioreactors. With the progress in the understanding of the molecular and cellular mechanisms regulating HSPCs maintenance and expansion, more recent approaches have involved transcription regulation, cell cycle regulation, telomerase regulation, and chromatin-modifying agents. The potential clinical application and safety issues relevant to the expanded HSPCs are also discussed in this review. Am. J. Hematol. 83:922-926, 2008. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:922 / 926
页数:5
相关论文
共 68 条
  • [1] Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts
    Ahmed, N
    Khokher, MA
    Hassan, HT
    [J]. STEM CELLS, 1999, 17 (02) : 92 - 99
  • [2] HOXB4-induced expansion of adult hematopoietic stem cells ex vivo
    Antonchuk, J
    Sauvageau, G
    Humphries, RK
    [J]. CELL, 2002, 109 (01) : 39 - 45
  • [3] Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents
    Araki, H
    Mahmud, N
    Milhem, M
    Nunez, R
    Xu, MJ
    Beam, CA
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2006, 34 (02) : 140 - 149
  • [4] Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
    Araki, Hiroto
    Yoshinaga, Kazumi
    Boccuni, Piernicola
    Zhao, Yan
    Hoffman, Ronald
    Mahmud, Nadim
    [J]. BLOOD, 2007, 109 (08) : 3570 - 3578
  • [5] Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells
    Burns, JS
    Abdallah, BM
    Guldberg, P
    Rygaard, J
    Schroder, HD
    Kassem, M
    [J]. CANCER RESEARCH, 2005, 65 (08) : 3126 - 3135
  • [6] Cell cycle inhibitors in normal and tumor stem cells
    Cheng, T
    [J]. ONCOGENE, 2004, 23 (43) : 7256 - 7266
  • [7] Chi Zhan-You, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P622
  • [8] Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells
    Chun-Gang Xie
    Jin-Fu Wang
    Ying Xiang
    Li-Yan Qiu
    Bing-Bing Jia
    Li-Juan Wang
    Guo-Zhong Wang
    Guo-Ping Huang
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (03) : 393 - 402
  • [9] Hematopoietic stem-cell transplantation using umbilical-cord blood
    Cohen, Y
    Nagler, A
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (08) : 1287 - 1299
  • [10] Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells
    De Felice, LD
    Tatarelli, C
    Mascolo, MG
    Gregorj, C
    Agostini, F
    Fiorini, R
    Gelmetti, V
    Pascale, S
    Padula, F
    Petrucci, MT
    Arcese, W
    Nervi, C
    [J]. CANCER RESEARCH, 2005, 65 (04) : 1505 - 1513